Rising Demand in Cancer Immunotherapy and Autoimmune Research Drives IL-2 Market Growth

Kanishk Kumar Kanishk Kumar
Aug 3, 2025 - 20:09
0 33

Share this Post to earn Money ( Upto ₹100 per 1000 Views )


Rising Demand in Cancer Immunotherapy and Autoimmune Research Drives IL-2 Market Growth

Growing cancer immunotherapy demand, autoimmune research, and IL-2's role in CAR-T/NK therapies drive market growth. Key players: Novartis (Proleukin), Alkermes, NeoImmuneTech, Eli Lilly, and Nektar Therapeutics. Engineered IL-2 variants and combination therapies fuel innovation in this expanding immunology sector.

Explore IL-2 Market Insights:

https://www.delveinsight.com/infographics/interleukin-2-market-forecast?utm_source=infographics&utm_medium=promotion&utm_campaign=kkpr